Traitement de 1^re ligne = First line treatmentBUNEL, V; BERGHMANS, T.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 121-125, issn 1877-1203, 5 p.Article

Effect of Curcumin on Inflammation and Oxidative Stress in Cisplatin-lnduced Experimental NephrotoxicityKUHAD, Anurag; PILKHWAL, Sangeeta; SHARMA, Sameer et al.Journal of agricultural and food chemistry (Print). 2007, Vol 55, Num 25, pp 10150-10155, issn 0021-8561, 6 p.Article

Cisplatin: mode of cytotoxic action and molecular basis of resistanceSIDDIK, Zahid H.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7265-7279, issn 0950-9232, 15 p.Article

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatinNAKAYAMA, Kentaro; TAKEBAYASHI, Yuji; NAKAYAMA, Satoru et al.Cancer letters. 2003, Vol 192, Num 2, pp 227-235, issn 0304-3835, 9 p.Article

Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatinPETERS, Ulrike; PREISLER-ADAMS, S; LANVERS-KAMINSKY, Claudia et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1249-1255, issn 0250-7005, 7 p.Article

ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatinYOSHIDA, K; OZAKI, T; FURUYA, K et al.Oncogene (Basingstoke). 2008, Vol 27, Num 8, pp 1183-1188, issn 0950-9232, 6 p.Article

Cell response of Escherichia coli to cisplatin-induced stressSTEFANOPOULOU, Maria; KOKOSCHKA, Malte; SHELDRICK, William S et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 21, pp 4174-4188, issn 1615-9853, 15 p.Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Pharmacokinetics and pharmacodynamics of cisplatin after intra-operative Hyperthermic intraperitoneal chemoperfusion (HIPEC)ZEAMARI, S; FLOOT, B; VAN DER VANGE, N et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1643-1648, issn 0250-7005, 6 p.Article

Functional consequences of PRPF39 on distant genes and cisplatin sensitivitySTARK, Amy L; DELANEY, Shannon M; WHEELER, Heather E et al.Human molecular genetics (Print). 2012, Vol 21, Num 19, pp 4348-4355, issn 0964-6906, 8 p.Article

Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatinYAZLOVITSKAYA, Eugenia M; PERSONS, Diane L.Anticancer research. 2003, Vol 23, Num 3B, pp 2275-2279, issn 0250-7005, 5 p.Article

Molecular mechanisms of hyperthermia- and cisplatin-induced cytotoxicity in T cell leukemiaMAUZ-KORHOLZ, C; DIETZSCH, S; SCHIPPEL, P et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2643-2647, issn 0250-7005, 5 p.Article

Relation between intracellular accumulation and cytotoxic activity of cis-[((1R, 2R)-1,2-cyclohexanediamine-N, N')bis(myristato)]platinum(II) suspended in lipiodolKISHIMOTO, Shuichi; OHTANI, Aya; FUKUDA, Hisayuki et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 5, pp 683-686, issn 0918-6158, 4 p.Article

Evaluation of cisplatin + 5-Fu, carboplatin + 5-Fu, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosaTORRES-BUGARIN, O; VENTURA-AGUILAR, A; ZAMORA-PEREZ, A et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2003, Vol 539, Num 1-2, pp 177-186, issn 1383-5718, 10 p.Article

Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cellsDEL BELLO, Barbara; VALENTINI, Marta A; ZUNINO, Franco et al.Oncogene (Basingstoke). 2001, Vol 20, Num 33, pp 4591-4595, issn 0950-9232Article

Magnetic core-mesoporous shell nanocarriers with drug anchorages suspended in mesopore interior for cisplatin deliveryXIANGYANG ZHU; JINLOU GU; YONGSHENG LI et al.Microporous and mesoporous materials. 2014, Vol 196, pp 115-121, issn 1387-1811, 7 p.Article

Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cellsSHETTY, Vivekananda; NICKENS, Zacharie; TESTA, James et al.Journal of proteomics (Print). 2012, Vol 75, Num 11, pp 3270-3290, issn 1874-3919, 21 p.Article

DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligandPROKOP, Radim; KASPARKOVA, Jana; NOVAKOVA, Olga et al.Biochemical pharmacology. 2004, Vol 67, Num 6, pp 1097-1109, issn 0006-2952, 13 p.Article

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2CIARIMBOLI, Giuliano; LUDWIG, Thomas; LANG, Detlef et al.The American journal of pathology. 2005, Vol 167, Num 6, pp 1477-1484, issn 0002-9440, 8 p.Article

RAB8 Enhances TMEM205-Mediated Cisplatin ResistanceSHEN, Ding-Wu; GOTTESMAN, Michael M.Pharmaceutical research. 2012, Vol 29, Num 3, pp 643-650, issn 0724-8741, 8 p.Article

Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cellsARORA, Sanjeevani; KOTHANDAPANI, Anbarasi; TILLISON, Kristin et al.DNA repair. 2010, Vol 9, Num 7, pp 745-753, issn 1568-7864, 9 p.Article

Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicityCHIRINO, Yolanda I; PEDRAZA-CHAVERRI, José.Experimental and toxicologic pathology (Print). 2009, Vol 61, Num 3, pp 223-242, issn 0940-2993, 20 p.Article

Utilization of a Right-handed Coiled-coil Protein from Archaebacterium Staphylothermus marinus as a Carrier for CisplatinERIKSSON, Mathilda; HASSAN, Saadia; DALIANIS, Tina et al.Anticancer research. 2009, Vol 29, Num 1, pp 11-18, issn 0250-7005, 8 p.Article

Kinase activity-independent suppression of p73a by AMP-activated kinase a (AMPKa)LEE, Y.-G; LEE, S.-W; SIN, H.-S et al.Oncogene (Basingstoke). 2009, Vol 28, Num 7, pp 1040-1052, issn 0950-9232, 13 p.Article

Mechanisms of resistance to cisplatin and carboplatinSTEWART, David J.Critical reviews in oncology/hematology. 2007, Vol 63, Num 1, pp 12-31, issn 1040-8428, 20 p.Article